Company No: 10446033 (England and Wales)

Contents

• Balance Sheet
• Notes to the Financial Statements

		2025		2024
		£		£
Fixed assets		550,029		462,681
Current assets		63,095		103,693
Prepayments and accrued income		1,052		903
Creditors: amounts falling due within one year		( 13,831)		( 33,131)
Net current assets		50,316		71,465
Total assets less current liabilities		600,345		534,146
Accruals and deferred income		( 5,866)		( 3,528)
Net assets		594,479		530,618
Capital and reserves		594,479		530,618

For the financial year ending 31 October 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements;
• These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime;
• These financial statements have been delivered in accordance with the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Pain & Neuromodulation Consulting Ltd (registered number: 10446033) were approved and authorised for issue by the Board of Directors and were signed on its behalf by:

Dr Simon James Thomson Director

30 July 2026

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 10446033). The address of its registered office is 1 The Atrium Phoenix Square, Wyncolls Road, Colchester, CO4 9AS, United Kingdom.

2. Employees

	2025		2024
	Number		Number
Monthly average number of persons employed by the Company during the financial year, including directors	4		4

3. Directors’ benefits: advances, credit and guarantees

Advances

During the year advances of £888 were made to the directors.
Amounts repaid during the year totalled £744.
At the year year end the Company was owed £888 by the directors (2024: £744). The balance is interest-free and repayable on demand.